Finding the best order of treatments for anxious depression
Treatments studied
Part of Mental health clinical trials.
This study tests which treatment sequence works best for people with anxiety conditions (generalized, social, separation) and/or panic, who also have significant depression/anxiety symptoms. It may help you find a more effective step-by-step plan and compare treatment orders.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 to 50 years old and able to read and understand English for the study visits
- Your main diagnosis must be generalized anxiety, social anxiety, separation anxiety, and/or panic disorder (not something else)
- Your anxiety severity must be high enough at two visits (HAM-A 20+ at Visits 1 and 2 and CGI-S 4+ at both visits)
- You must have a normal physical exam and no concerning heart rhythm result on an EKG (QTc not too high)
- If you can become pregnant, you must have a negative pregnancy test and use reliable birth control during the study and for at least 30 days after
- You must test negative for drugs at the start and be able to swallow capsules
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a step-by-step approach to treating moderate-to-severe depression in teens. It may help find a treatment path that improves mood while keeping care safe, including for some teens who have suicidal thoughts but do not need inpatient care.
This Phase 2 trial tests OSU6162 added to an SSRI or SNRI in people whose major depression did not improve enough after trying specific antidepressants for at least 6 weeks. It may help reduce depression symptoms when standard treatments haven’t worked well.
This trial studies whether an antidepressant can help teens (ages 12–17) with anxiety disorders such as generalized, social, separation, or panic anxiety. It looks at both early and longer-term success of treatment, while monitoring safety closely with a caregiver.
This study tests whether a genetics-guided approach to choosing and adjusting escitalopram (an anxiety medicine) can improve safety and effectiveness for anxious teens. It also checks that participants have certain anxiety severity scores and can safely take the study medication.
This Phase 4 study tests an “optimized” medication approach for adults with major depressive disorder (unipolar depression) based on how you respond over time. It may help your care team choose treatments more effectively and reduce trial-and-error.
This trial tests whether escitalopram, a common antidepressant, helps people who are experiencing their first episode of depression and have never taken medication for it. It also looks at how the drug works in the brain.
Hear when a new Anxious Depression trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.